SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-275207
Filing Date
2023-11-13
Accepted
2023-11-13 06:07:53
Documents
12
Period of Report
2023-09-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d514976d8ka.htm   iXBRL 8-K/A 26586
  Complete submission text file 0001193125-23-275207.txt   154642

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA chrs-20230908.xsd EX-101.SCH 2852
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20230908_lab.xml EX-101.LAB 18703
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20230908_pre.xml EX-101.PRE 11697
6 EXTRACTED XBRL INSTANCE DOCUMENT d514976d8ka_htm.xml XML 4651
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36721 | Film No.: 231394689
SIC: 2836 Biological Products, (No Diagnostic Substances)